The experience builds on BAT’s open and transparent approach to the science underpinning its reduced-risk product portfolio and beyond nicotine activities. The company regularly welcomes visitors in person to its global R&D hub, with more than 3,500 people viewing the facilities first-hand since 2011. However, with travel significantly reduced, the virtual experience allows people from across the globe to access and understand BAT’s scientific research, Tobacco Harm Reduction (THR) activities, and gain perspectives and insights from experts, BAT said.
Dr David O’Reilly, Director, Scientific Research at BAT, commented: “At BAT R&D is fundamental to what we do. Our focus on science and research has enabled us to make significant progress in developing and evolving our New Category products, which are rigorously tested and scientifically substantiated as reduced-risk alternatives to cigarettes. Our R&D is based around consumer preferences, as well as applying evolving science and innovation to our products. This allows us to offer a range of enjoyable, reduced-risk alternatives to cigarettes, while ensuring we maintain very high safety and quality standards.
“Our new R&D Virtual Visitor Experience demonstrates the breadth of science we are undertaking and the robust scientific framework we use to evaluate and support the role our products play in delivering Tobacco Harm Reduction.”
With 360-degree lab tours, animations, videos, scientist profiles, podcasts, and more, the R&D Virtual Visitor Experience is the one-stop hub for those looking to find out about BAT’s science. The tour illuminates BAT’s purpose to build A Better Tomorrow™ and mission to reduce the health impact of its business. BAT invests almost GBP 350 million a year to find innovative ways to reduce its effects on public health and aims to have 50 million consumers of its non-combustible products by 2030, the press release said.
To find out more, visit BAT-Science.com